Categories: AntimicrobialNews

RushNet Names Arizona Businessman Michael Cunha as Chairman and Chief Executive Officer

PHOENIX, AZ / ACCESSWIRE / March 4, 2024 / RushNet, Inc (OTC PINK:RSHN), (the “Company”) announced today the appointment of Michael Cunha as its new Chairman and Chief Executive Officer, effective immediately. Mr. Cunha assumes these roles following the resignation of Ashley Sweat, who has decided to explore other opportunities. The Company extends its best wishes to Mr. Sweat for success in his future endeavors and expresses gratitude for his past contributions. It’s important to note that the incoming management team has no prior affiliations with any former management teams of RushNet.

Mr. Cunha, the new Chairman and Chief Executive Officer of Rushnet commented, “I have run very successful private companies in my career, and this is my first experience with a public company. We are immediately transitioning out of the lab business, and we will announce our new business direction within the next few days.”

Mr. Cunha is a distinguished Arizona-based entrepreneur renowned for his track record of establishing thriving enterprises. He attained academic excellence, graduating summa cum laude from Washington State University with a Bachelor of Science in Psychology, and later achieving the same honor at Chapman University, where he earned his MBA in Accounting and Economics.

With an extensive background spanning over three decades in manufacturing, accounting, finance, and executive leadership, Mr. Cunha brings a wealth of experience to the table. Notably, he served as the Corporate Controller of Andermac, Inc., a medical equipment manufacturer, for a duration of eight years. During his tenure, Mr. Cunha spearheaded initiatives that led to the company’s automation, resulting in substantial market expansion. Under his guidance, Andermac achieved a dominant market share of 50% in California and 25% nationwide.

In late 1991, Mr. Cunha embarked on a new venture by co-founding InterMag, Inc., a magnetic media manufacturing company, alongside four partners. Assuming responsibilities in finance and manufacturing, Mr. Cunha played a pivotal role in securing the company’s inaugural contract with Iomega for the production of Iomega 100mb Zip disks. Under his leadership, InterMag experienced remarkable growth, scaling from inception to a revenue of $72 million within a span of three years. In 1995, InterMag was sold to the second largest magnetic media company in Taiwan.

In 1996, Mr. Cunha, alongside two business partners, established what has evolved into Mionix Corporation. Mionix has emerged as a frontrunner in human and animal feed additive antimicrobials, with notable contributions such as the development and promotion of a feed additive aimed at regulating gut bacteria in shrimp, a significant achievement in Southeast Asia. Mionix Corporation underwent a successful acquisition in June 2015. Presently, Mr. Cunha serves as the Managing Member of Patmos Holdings I, LLC, a holding company dedicated to investing in early-stage companies.

About RushNet

With over 25 years in the public sector, RushNet has continually evolved, embracing change and innovation at every turn. The company is completing its transition out of the lab business.

CONTACT:

Michael Cunha
Phone 916-616-7037
Email mcunha53@gmail.com
Twitter Handle: @rushnetrevival

Safe Harbor Notice

Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). The Company cautions that the statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.

SOURCE: RushNet

View the original press release on accesswire.com

Staff

Recent Posts

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 hours ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

3 hours ago

Thought Technology Ltd Celebrates 50 Years of Innovation and Excellence

Montreal-based Thought Technology Ltd wraps up its 50th year in business providing psychophysiological instrumentation to…

3 hours ago

Study Finds Telemedicine Improves Care for Children with Eye Cancer

The new research from eye care nonprofit Orbis International, supported by Heidelberg Engineering, shows how…

3 hours ago

Net Health Looks Ahead to 2025 with Continued Momentum as a Leading Health Tech Partner

Business wins, strategic collaborations, and renewed commitment to client partnership highlight a year of transformation…

3 hours ago

Pioneers in Pediatrics

Board member Drew Neville and the rest of the team at Children's Health Foundation of…

6 hours ago